AAM All Access Podcast - Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.

NEW: 2022 U.S. Generic & Biosimilar Medicines Savings Report

Savings continue to grow with $373B saved in 2021 the U.S. health care system, including patients, employers, and taxpayers. With 91% of Rx filled and only 18% of Rx drug spending, findings reinforce the critical importance of the generic and biosimilar industry to America’s patients.

Read Press Release
Explosive Growth in Drug Discount Cards is a Symptom of a Broken System

A new white paper from IQVIA shines light not only on the growth of these cards, but also on how much patients are unnecessarily spending on low-cost generic drugs.

Read Blog
Biosimilars Patient Resource Center

Your one-stop-shop for everything patients and health care professionals need to know about biosimilar medicines. Check out helpful links and resources from the Biosimilars Council, the FDA and other organizations.

View Website
GRx+Biosims 2022

Join us at the premier scientific and regulatory event for the U.S. generics and biosimilars industry featuring timely programming relevant to technical, regulatory, policy professionals. November 7-9, North Bethesda, Maryland.

Register Now
AAM Voices of Access

Physicians, pharmacists, patients and caregivers across the country trust generics and biosimilars. Here are their stories, in their own words—along with perspectives from health care professionals and the AAM team.

View Report
Who’s Profiting from Your Prescription?

Unlike brand drugs where the manufacturer stands to profit the most, generic medicines are often exploited by middlemen that seize significant profits at the expense of patients and the companies that make the medicines.

Learn More
What Are GDUFA and BsUFA User Fees?

Watch this this video to learn more about how the Generic Drug User Fee Amendments (GDUFA) and Biosimilar User Fee Act (BsUFA) help to get more generic and biosimilar medicines to patients more quickly.
Watch Video
Generic Medicines Are Saving Your State Billions

In 2020, generic and biosimilar medicines saved America's patients $338 billion. Find out how much your state saved with our interactive savings map.

View Interactive Map

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers of generic and biosimilar medicines and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of generic and biosimilar medicines and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Policy

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable generic and biosimilar medicines. Learn More

About Us

The Association for Accessible Medicines improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

2022 2022 U.S Generic and Biosimilar Medicines Savings Report

Sep 21, 2022 | Susan Reilly

Generic and Biosimilar Drugs Generate A Record $373 Billion For America’s Patients and Healthcare System in 2021

2022 2022 U.S Generic and Biosimilar Medicines Savings Report

Sep 21, 2022 | Erica Klinger

Report: 2022 U.S. Generic and Biosimilar Medicines Savings Report

Avalere: New Analysis of Trends in Part D Generic Tiering, Pricing, and Patient Spending

Sep 15, 2022 | Susan Reilly

AAM Statement: New Study Shows Formulary Abuses Force Patients to Pay More for Generic Drugs Even as the Prices of Those Drugs Go Down

IQVIA White Paper: Pharmacy Discount Card Utilization and Impact

Sep 6, 2022 | Craig Burton

Explosive Growth in Drug Discount Cards is a Symptom of a Broken System

Video

Aug 23, 2022 | Ericka Nguyen

October's Story

Capitol Building - Washington D.C.

Aug 7, 2022 | Allen Goldberg

AAM Statement on Senate Passage of Inflation Reduction Act